Clinical Trials · NCT06966687
Protective Effect of Ulinastatin and Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI)
- Phase
- N/A
- Recruitment status
- Enrolling By Invitation
- Sponsor
- Nanjing Medical University
- Enrollment
- 200
- Start date
- Apr 2025
- Locations
- 4 sites, China
- Primary endpoint
- The mean Sequential Organ Failure Assessment (SOFA) score of 7 days after surgery